Micro-Yuan Synthesis Secures $42 Million in Funding, Launches AI Bio-Computation Platform
business#generative ai📝 Blog|Analyzed: Mar 30, 2026 00:00•
Published: Mar 30, 2026 00:00
•1 min read
•36氪Analysis
Micro-Yuan Synthesis's successful funding round and the launch of its AI bio-computation platform marks a significant step forward in integrating AI with biotechnology. This initiative, highlighted by the open-source PoseX platform, promises to revolutionize molecular docking and accelerate drug discovery and synthetic biology research.
Key Takeaways
- •Micro-Yuan Synthesis raised 300 million RMB in Series A+ funding.
- •The company is collaborating with leading universities and NVIDIA on the PoseX platform.
- •The platform aims to improve protein structure prediction for applications in synthetic biology.
Reference / Citation
View Original"The top AI docking methods (such as SurfDock) and co-folding methods (such as AlphaFold3), in dealing with the most challenging cross-conformation docking tasks, have comprehensively surpassed the physical models that have dominated the industry for decades."